Wearable device to remove extra fluid during dialysis
Part of Kidney & urinary clinical trials.
This trial tests a wearable device that may help remove extra fluid during dialysis, which could help you feel better and avoid extra treatment sessions. It is for people on hemodialysis who struggle with fluid buildup.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have hemodialysis three times a week.
- You use a central line (a tube in a large vein) for dialysis.
- In the last month, you often gain more than 4% of your dry weight between sessions, or you have trouble reaching your dry weight, or you need extra dialysis sessions to remove fluid.
- You are willing to give informed consent.
- You do not have an active infection and you stick to your dialysis schedule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special device to measure fluid levels in the body during dialysis. It may help doctors better understand and manage fluid balance for people on hemodialysis.
This trial tests a wearable device that removes extra fluid from your body without using the kidneys. It may help people with heart failure who still have fluid buildup despite taking high doses of water pills.
This study tests whether removing extra fluid during your regular dialysis sessions can help lower blood pressure and reduce fluid buildup. If you have kidney failure and are on hemodialysis, this could improve your heart health and well-being.
This trial tests whether a faster rate of fluid removal during dialysis can help hospitalized patients with end-stage kidney disease who have severe fluid buildup. It aims to reduce fluid congestion and improve outcomes.
This study compares a specific way of removing fluid during dialysis (isolated ultrafiltration) with conventional hemodialysis. It aims to see how each approach affects blood flow and fluid shifts in people with end-stage kidney disease.
This trial tests whether adding a special blood-filtering device (hemoadsorption) to your regular dialysis treatment can reduce uncomfortable symptoms caused by kidney failure, like fatigue or itching. Researchers will track how you feel over time compared to standard dialysis alone.
Hear when a new Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.